Author

Joan van Kregten

Observed names: Joan M.R van Kregten, Joan Van Kregten

Institution: Johnson & Johnson (United States)

Observed institutions: Johnson & Johnson (United States), BBB Therapeutics (Netherlands)

OpenAlex ID: A5033024549

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

2014 · Pieter J. Gaillard, Chantal C. M. Appeldoorn, et al. · PLoS ONE · 273

Glutathione PEGylated liposomes: pharmacokinetics and delivery of cargo across the blood–brain barrier in rats

2014 · Jaap Rip, Linda Chen, et al. · Journal of drug targeting · 149

Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo

2016 · David Maussang, Jaap Rip, et al. · Drug Discovery Today Technologies · 88

In vivo Functional Evaluation of Increased Brain Delivery of the Opioid Peptide DAMGO by Glutathione-PEGylated Liposomes

2015 · Annika Lindqvist, Jaap Rip, et al. · Pharmaceutical Research · 56

Abstract 5537: GSH-conjugation improves efficacy of Doxil against intracranial xenografts

2010 · Olaf van Tellingen, Dieta Brandsma, et al. · Cancer Research · 6

Establishment and optimization of an E. coli urinary tract infection model in Göttingen minipigs with strain recovery and characterization

2026 · Joyce Lübbers, Kaila Orlandini, et al. · Frontiers in Immunology

Works count: 8

Citation count: 572

H-index: 5

I10-index: 4